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Relationship between Myocardial Extracellular Space 
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Objective: Post-contrast T1 values are closely related to the degree of myocardial extracellular space expansion. We 
determined the relationship between post-contrast T1 values and left ventricular (LV) diastolic function, LV remodeling, and 
neurohormonal activation in patients with dilated cardiomyopathy (DCM).
Materials and Methods: Fifty-nine patients with DCM (mean age, 55 ± 15 years; 41 males and 18 females) who underwent 
both 1.5T magnetic resonance imaging and echocardiography were enrolled. The post-contrast 10-minute T1 value was 
generated from inversion time scout images obtained using the Look-Locker inversion recovery sequence and a curve-fitting 
algorithm. The T1 sample volume was obtained from three interventricular septal points, and the mean T1 value was used 
for analysis. The N-Terminal pro-B-type natriuretic peptide (NT-proBNP) level was measured in 40 patients.
Results: The mean LV ejection fraction was 24 ± 9% and the post-T1 value was 254.5 ± 46.4 ms. The post-contrast T1 value 
was significantly correlated with systolic longitudinal septal velocity (s’), peak late diastolic velocity of the mitral annulus 
(a’), the diastolic elastance index (Ed, [E/e’]/stroke volume), LV mass/volume ratio, LV end-diastolic wall stress, and LV 
end-systolic wall stress. In a multivariate analysis without NT-proBNP, T1 values were independently correlated with Ed (β = 
-0.351, p = 0.016) and the LV mass/volume ratio (β = 0.495, p = 0.001). When NT-proBNP was used in the analysis, NT-
proBNP was independently correlated with the T1 values (β = -0.339, p = 0.017).
Conclusion: Post-contrast T1 is closely related to LV remodeling, diastolic function, and neurohormonal activation in 
patients with DCM.
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INTRODUCTION
The development of dilated cardiomyopathy (DCM) 
requires the coexistence of myocardial dysfunction with 
a remodeling process that is mediated by wall stress and 
neurohormonal factors (1). DCM is an important cause 
of morbidity and mortality among patients with heart 
failure (2). Mortality rate of heart failure has decreased 
but remains at > 50% 5 years after the diagnosis (3). 
Both diastolic dysfunction and neurohormonal activation 
are important prognostic factors in patients with DCM. 
Markers of diastolic dysfunction correlate strongly with 
congestive symptoms and prognosis in these patients (4, 5). 
N-Terminal pro-B-type natriuretic peptide (NT-proBNP) is an 
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index of neurohormonal activation and is associated with 
higher mortality and hospitalization in patients with heart 
failure (6). Previous studies have shown that left ventricular 
(LV) remodeling is associated with the degree of myocardial 
fibrosis (7, 8). Cardiac fibrosis is an important contributor 
to diastolic dysfunction and is significantly correlated with 
NT-proBNP level (9, 10). The concentration of gadolinium 
in myocardium can be assessed from T1 measurements 
and used to quantify extracellular volume (ECV) of the 
myocardium (11). However, the structural determinants of 
diastolic dysfunction and neurohormonal activation remain 
undetermined in patients with DCM. We hypothesized that 
LV diastolic function and neurohormonal activation in 
patients with DCM are associated with post-contrast T1 
measured using the Look-Locker (LL) sequences.
MATERIALS AND METHODS
Study Population
A total of 122 patients diagnosed with idiopathic DCM 
at our institution were retrospectively enrolled in this 
study from May 2003 to August 2010. Idiopathic DCM was 
diagnosed in the presence of LV dilation associated with 
systolic dysfunction, in the absence of coronary artery 
disease, valvular heart disease, or congenital heart disease. 
Exclusion criteria included poor cardiac magnetic resonance 
imaging (CMR) quality (n = 14), lack of LL imaging or late 
gadolinium enhancement (LGE) images (n = 45), and an 
estimated glomerular filtration rate < 30 mL/min (n = 4). 
Finally, 59 patients (41 men; mean age, 55 ± 15 years) were 
included in the study. All study participants underwent both 
transthoracic echocardiography and CMR. Data on NT-proBNP 
levels were available for 40 of these patients. CMR and 
echocardiography were performed, and NT-proBNP levels were 
determined within 1 month of diagnosis. A retrospective 
review of medical records was conducted to obtain clinical 
data, electrocardiographic findings, and biological marker 
levels. Twelve cases (10 men; mean age, 47 ± 18 years), who 
underwent CMR for an evaluation of chest pain but had no 
significant cardiovascular disease, were enrolled as a control 
group. All study participants in the control group also 
underwent transthoracic echocardiography and had normal 
LV systolic function. Mean LV ejection fraction was 65.7 
± 5.5% (range, 58–74%) in the control group. The study 
protocols were approved by our Institutional Review Board, 
and informed consent from patients was waived due to the 
retrospective nature of the study.
Echocardiography
All patients underwent a comprehensive echocardiographic 
examination, as described previously (12). LV end-diastolic 
and end-systolic diameters were obtained from the two-
dimensional parasternal long-axis or short-axis view. The 
peak velocity of early diastolic filling (E), late diastolic 
filling, and deceleration time of the E wave velocity were 
measured using the pulsed-wave Doppler method at the 
level of the mitral valve leaflet tips in apical four-chamber 
views. Peak early diastolic velocity (e’), late diastolic 
velocity (a’), and peak systolic velocity of the mitral 
annulus (s’) were measured by tissue Doppler imaging from 
the septal mitral annulus in apical four-chamber views. 
The E/e’ ratio was calculated to estimate LV filling pressure 
(13-15). We calculated the diastolic elastance index (Ed), 
estimated as E/e’ divided by the filling volume during 
diastole (stroke volume), as used in a previous study to 
measure diastolic function as a continuous variable (16). 
End-systolic pressure was estimated as (2 x systolic pressure 
+ diastolic pressure) / 3 (16, 17). All parameters were 
measured in three consecutive beats, and mean values were 
used for further calculations.
NT-proBNP Blood Sampling
The blood samples for plasma NT-proBNP levels were 
obtained by antecubital vein puncture, collected into 
ethylenediaminetetraacetic acid tubes, and placed on ice. 
Each sample was centrifuged for 5 minutes at 2000 x g and 
at 4°C for 30 minutes. The plasma was separated, frozen, 
and stored at -80°C until assessment. NT-proBNP levels were 
measured with a proBNP assay on an Elecsys 2010 analyzer 
(Roche Diagnostics, GmbH, Mannheim, Germany). According 
to data provided by the manufacturer, the detection limit 
for this peptide was 5 pg/mL.
Cardiac MRI Protocols
Cardiac MR imaging was performed using a 1.5T 
Gyroscan Intera system (Philips Medical Systems, Best, 
the Netherlands). Steady-state free precession gated cine 
images were acquired during 8 seconds breath holds in the 
long-axis plane and sequential 10 mm short-axis slices, as 
described previously (18, 19). Contrast-enhanced delayed 
images were obtained 10–15 minutes after intravenous 
injection of 0.2 mmol/kg gadolinium diethylenetriamine 
pentaacetic acid. A standard mid-LV short-axis section 
orientation was used for inversion time (TI) scout images 
for LGE imaging with the LL inversion recovery sequence 
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(20, 21). LL single-slice TI scout imaging was performed 10 
minutes after contrast injection. The LL sequence comprised 
12 ms increments in the mid LV short-axis slice. Flip angle 
was 8°, echo time was 2.40 ms, and repetition time was 5.87 
ms. LGE imaging was performed 15 minutes after contrast 
injection. Two-dimensional LGE imaging was used. The range 
of inversion recovery time was 220–300 ms. If myocardial 
signal intensity was higher than that of the shoulder 
muscle, inversion time was shortened by 10–20 ms, and the 
scan was repeated. Sequential, short-axis, 1-cm thick slices 
were obtained. Myocardial regions with abnormally high 
signals, as determined by two experienced radiologists, 
were considered positive for LGE. We used commercially 
available software (QMass MR, version 7.5, Medis, Leiden, 
the Netherlands) to quantify the post-contrast T1 values. 
The post-contrast 10-minute T1 value was generated from 
TI scout images obtained by the LL inversion recovery 
sequence using a curve-fitting algorithm (Fig. 1). About 
0.6 x 0.6 cm sized round shaped region-of-interests were 
placed in the mid-wall of the upper- and lower-right 
ventricle-septal insertion site and mid-septum for T1 
measurements regardless of the presence of LGE, because 
movement of the ventricular septum was relatively less than 
in other LV areas. Then their average values were used for 
further analysis. T1 measurements were obtained twice by 
the same observer who was blinded to other clinical data 
in 10 selected cases. The ventricular volumes, LV ejection 
fraction, and stroke volume were measured by stacking 
endocardial and epicardial border tracings in each short-
axis slice. Blood pressure and heart rate were also measured 
during CMR.
Wall Stress Index
The LV mass index was calculated as: LV mass/body 
surface area. LV-end diastolic wall stress (LVEDWS, mm Hg) 
was calculated as: (estimated LV end-diastolic pressure) 
/ {([LVEDV + LV mass] / LVEDV)2/3 - 1} from LaPlace’s 
law, where the estimated LV end-diastolic pressure was 
calculated from the equation (1.9 + 1.24 x [E/e’]) (15, 22). 
Similarly, LV-end systolic wall stress (LVESWS, mm Hg) was 
calculated as (estimated end-systolic pressure) / {([LVESV 
+ LV mass] / LVESV)2/3 - 1}. Where, LVEDV and LVESV means 
left ventricular end-diastolic volume and left ventricular 
end-systolic volume, respectively.
Fig. 1. Representative case of measuring post-T1 value in Look-Locker-based inversion time scout images.
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Statistical Analysis
The statistical analysis was performed using SPSS ver. 
18.0 for Windows software (SPSS Inc., Chicago, IL, USA). 
All continuous variables are expressed as mean ± standard 
deviation. Discrete variables were compared using Fisher’s 
exact test. Continuous variables were compared using the 
independent t test. Pearson’s correlation analysis was used 
for the univariate analysis to find the determinants of post-
contrast T1 relaxational time, and a stepwise multiple linear 
regression analysis was used for the multivariate analysis. 
Variables with a p value < 0.05 in the univariate analysis 
were included in the multivariate analysis. LV mass was 
not included in the multivariate analysis for post-contrast 
T1 values without NT-proBNP due to significant colinearity 
with the LV mass/volume ratio, which is a better correlate 
for post-contrast T1. A two-sided probability value of p < 
0.05 was considered significant.
RESULTS
Baseline Clinical Characteristics and CMR Findings
Thirty-seven (68.5%) of 59 patients were classified New 
York Heart Association class III or IV. LV dilatation (LVEDV, 
308.3 ± 129.0 mL; LVESV, 239.7 ± 116.9 mL) with severely 
reduced ejection fraction (23.8 ± 9.3%) was measured by 
CMR. Mean velocity was also significantly reduced (3.8 ± 1.2 
cm/s). The mean E/e’ value increased to 19.7 ± 9.4. Plasma 
NT-proBNP levels ranged from 33 pg/mL to 18077 pg/mL, 
and the median value was 3034 pg/mL. Of the 59 patients, 
38 (64%) showed LGE on CMR. Septal and mid-wall LGE 
patterns were seen in 29 (49.2%) and 19 patients (32.2%), 
respectively. The mean T1 value was 254.5 ± 46.4 ms (Table 
1). Mean post-contrast T1 value was significantly longer 
in the control group, than that in the DCM group (303.3 
± 48.1 ms vs. 254.5 ± 46.4 ms, p = 0.002). The intraclass 
correlation coefficient for the post-T1 value between the 10 
selected cases was 0.9.
Presence of LGE, Diastolic Function, and NT-proBNP
Patients with LGE had significantly lower post-contrast 
T1 values and higher NT-proBNP levels than those without. 
In addition, patients with LGE had a lower LV mass/volume 
ratio, e’, a’, s’, and LV ejection fraction and higher E/e’, 
LVEDWS, and LVESWS than patients without LGE (Table 2).
Correlation with Post-Contrast T1 Values
Among the echocardiographic variables, s’ (r = 0.419, p 
= 0.002), a’ (r = 0.364, p = 0.023), and Ed (r = -0.288, p = 
0.027) were significantly correlated with post-contrast T1 
values. The correlation between the ejection fraction and 
post-contrast T1 values was not statistically significant. 
LV mass (r = 0.297, p = 0.019), LV mass/volume ratio 
(r = 0.388, p = 0.002), LVEDWS (r = -0.298, p = 0.023), 
and LVESWS (r = -0.380, p = 0.004) determined by CMR 
were also significantly correlated with post-contrast T1 
values. The NT-proBNP values measured in 40 patients 
were significantly correlated with the post-contrast T1 
value (r = -0.464, p = 0.003) (Table 3). In these patients, 
s’, e’, a’, Ed, LV mass, LVEDWS, and NT-proBNP were 
significantly correlated with the post-contrast T1 values. 
In the multivariate analysis without NT-proBNP, Ed (β = 
-0.466, p = 0.013) and LV mass/volume ratio (β = 0.694, 
p = 0.018) were significantly correlated with the post-
contrast T1 values. However, in the multivariate analysis 
with NT-proBNP, only NT-proBNP was significantly and most 
strongly correlated with the post-contrast T1 values (β = 
-0.423, p = 0.029) (Table 4). In addition, the association 
between the T1 value, the LV mass/volume ratio, and NT-
proBNP remained significant even after further adjustment 
for LGE, septal LGE, and mid-wall LGE (Table 5). In the 
subgroup analysis of patients without LGE, post-contrast 
T1 values were significantly correlated with the LV mass/
volume ratio (r = 0.494, p = 0.023). Furthermore, NT-
proBNP was significantly correlated with LVEDWS. However, 
when LGE or the post-contrast T1 values were considered 
in a subgroup analysis, a significantly weaker relationship 
was noted (β = 0.237, p = 0.124 after post-contrast T1). 
However, the relationship between post-contrast T1 and NT-
proBNP remained significant after adjusting for LVEDWS (β 
= -0.381, p = 0.016).
DISCUSSION
This study confirmed the relationship between LGE and 
more advanced systolic and diastolic dysfunction, higher LV 
wall stress, LV remodeling, and elevated NT-proBNP levels, 
in patients with non-ischemic DCM. Furthermore, the post-
contrast T1 relaxational time, an index of extracellular 
myocardial volume expansion, was reliably measured from 
TI scout images widely used in all CMR machines without 
additional imaging. Post-contrast myocardial T1 relaxational 
time was related to LV remodeling, LV compliance, and 
neurohormonal activation as assessed by elevated plasma 
NT-proBNP levels independent of LGE. 
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Non-Invasive Measurement of Extracellular Space 
Expansion 
Late gadolinium enhancement imaging is widely used 
to detecting extracellular space expansion or replacement 
fibrosis. The presence of LGE or various patterns of LGE 
in patients with non-ischemic cardiomyopathy provides 
important insight into myocardial pathology. However, 
current LGE imaging cannot provide the degree of diffuse 
interstitial fibrosis or expansion, which exists in all 
patients with non-ischemic DCM. Because LGE is present 
in only 30–60% of patients with DCM and the amount of 
LGE reaches at most 10% of the entire LV myocardium, an 
accurate assessment of the tissue characteristics of non-LGE 
myocardium is essential for understanding the microscopic 
structure and functional interaction. Direct T1 values 
measured with T1 mapping can provide information on 
Table 1. Clinical, Echocardiographic, and CMR Findings of Study Populations
DCM Control P
Clinical findings
Age (years)   55.3 ± 15.4   46.7 ± 18.0 0.091
Male 41/59 (69.5%)    10/12 (83.3%) 0.488
Initial NYHA   2.8 ± 0.7   1.2 ± 0.4 < 0.001
Systolic blood pressure (mm Hg) 110.8 ± 18.2 121.3 ± 10.6 0.059
Diastolic blood pressure (mm Hg)   71.0 ± 13.9 72.1 ± 6.1 0.674
Hypertension 15/52 (28.8%)   6/12 (50%) 0.185
Diabetes 15/51 (29.4%)     2/12 (16.7%) 0.487
eGFR (mL/min)   70.3 ± 23.1 86.7 ± 27.3 0.033
NT-proBNP (pg/mL, n = 40) 4067.3 ± 4063.6 (median) - -
Aspirin 32/53 (60.4%)     4/12 (33.3%) 0.114
Beta-blocker 36/54 (66.7%)   3/12 (25%) 0.011
Diuretics 50/54 (92.6%)     4/12 (33.3%) < 0.001
Angiotensin converting enzyme inhibitor 52/54 (96.3%)   6/12 (50%) < 0.001
Echocardiographic findings
E velocity (cm/s)   81.4 ± 28.2   76.7 ± 17.6 0.492
A velocity (cm/s)   57.0 ± 24.3   58.3 ± 21.1 0.882
E/A   1.7 ± 1.0   1.3 ± 0.4 0.091
s’ (cm/s)   3.8 ± 1.2   8.0 ± 2.2 < 0.001
e’ (cm/s)   4.5 ± 1.6   8.7 ± 3.0 0.001
a’ (cm/s)   5.4 ± 2.2   8.8 ± 2.8 < 0.001
E/e’ 19.7 ± 9.4   9.4 ± 5.0 0.001
Echocardiographic + CMR findings
LVEDWS (mm Hg)  102.4 ± 63.2 26.7 ± 2.9 0.095
LVESWS (mm Hg)   281.9 ± 100.6 101.0 ± 17.7 0.006
CMR findings
LVEDV (mL)   308.3 ± 129.0 146.9 ± 42.3 < 0.001
LVESV (mL)   239.7 ± 116.9   55.3 ± 18.9 < 0.001
Stroke volume (mL)   66.4 ± 24.0   91.7 ± 27.5 0.004
LV ejection fraction (%) 23.8 ± 9.3 62.2 ± 6.3 < 0.001
LV mass (g) 145.9 ± 53.4 80.8 ± 6.1 < 0.001
LV mass/volume ratio (g/mL)    0.5 ± 0.19     0.8 ± 0.33 0.246
LGE 38/59 (64.4%) 0/12 (0%) < 0.001
Septal LGE 29/59 (49.2%) 0/12 (0%) 0.001
Mid-wall LGE 19/59 (32.2%) 0/12 (0%) 0.028
Post-contrast T1 value (ms) 254.5 ± 46.5 303.3 ± 48.1 0.002
A = late diastolic transmitral inflow, a’ = late diastolic mitral annular velocity, CMR = cardiac magnetic resonance imaging, DCM = 
dilated cardiomyopathy, E = early diastolic transmitral inflow, e’ = early diastolic mitral annular velocity, eGFR = estimated glomerular 
filtration rate, LGE = late gadolinium enhancement, LV = left ventricular, LVEDWS = left ventricular end-diastolic wall stress, LVESWS = 
left ventricular end-systolic wall stress, NT-proBNP = N-Terminal pro-B-type natriuretic peptide, NYHA = New York Heart Association, s’ = 
systolic mitral annular velocity
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myocardial tissue characteristics. The extracellular contrast 
distribution mechanism allows for obtaining information 
about the degree of extracellular space expansion using 
the post-contrast T1 value (23). Therefore, the post-
contrast T1 value can be used as a surrogate marker of the 
ECV fraction. The most common approach to measure LV 
T1 values by CMR is the LL sequence. The LL sequence has 
been widely implemented by MRI scanner manufacturers for 
many years. The recently introduced modified LL inversion 
recovery (MOLLI) sequence is currently the most widely 
used gold standard for T1 mapping. The MOLLI sequence 
has the advantage of determining T1 during the same phase 
of the cardiac cycle, with potential for a more accurate T1 
measurement with less heart rate dependence. However, 
the MOLLI technique has limited availability, whereas the 
LL sequence is commonly used as a sequence for TI scout 
images. Therefore, an abundance of retrospective data is 
available for the LL sequence. As our study was designed 
Table 2. Comparison of Left Ventricular Systolic, Diastolic Function, Wall Stress, and Post-Contrast T1 Values According to 
Presence of Late Gadolinium Enhancement
LGE Absence (n = 21) LGE Presence (n = 38) P
E/A ratio 1.22 ± 0.82   1.99 ± 1.03 0.017
e’, cm/s 5.12 ± 1.58   4.21 ± 1.52 0.033
E/e’ 16.1 ± 5.73   21.64 ± 10.43 0.028
s’, cm/s 4.34 ± 1.27   3.54 ± 1.10 0.026
a’, cm/s 6.91 ± 1.97   4.60 ± 1.98 0.001
LVEDWS, mm Hg 82.97 ± 38.79 145.69 ± 84.03 < 0.001
LVESWS, mm Hg 272.27 ± 96.78   302.91 ± 108.13 0.289
LV mass/volume ratio 0.58 ± 0.19   0.47 ± 0.18 0.034
LV ejection fraction, % 27.5 ± 10.6 20.2 ± 6.8 0.008
Log NT-proBNP, pg/mL 2.89 ± 0.66   3.56 ± 0.41 < 0.001
Post-T1, ms 256.3 ± 40.7 250.8 ± 57.9 0.024
A = late diastolic transmitral inflow, a’ = late diastolic mitral annular velocity, E = early diastolic transmitral inflow, e’ = early diastolic 
mitral annular velocity, LGE = late gadolinium enhancement, LV = left ventricular, LVEDWS = left ventricular end-diastolic wall stress, 
LVESWS = left ventricular end-systolic wall stress, NT-proBNP = N-Terminal pro-B-type natriuretic peptide, s’ = systolic mitral annular 
velocity
Table 3. Association with Post-Contrast T1 Value by Univariate and Multivariable Analysis without NT-proBNP (n = 59)
Univariate Analysis Multivariate Analysis*
r P β P
Age 0.05 0.709
eGFR -0.09 0.496
LVEDV -0.039 0.767
LVESV -0.071 0.592
Stroke volume 0.169 0.201
LV ejection fraction 0.245 0.061
LV mass (CMR) 0.297 0.019
LV mass/volume ratio 0.388 0.002 0.495 0.001
E/e’ -0.159 0.228
s’ 0.419 0.002
e’ 0.254 0.052
a’ 0.364 0.023
E/e’/stroke volume (= Ed) -0.288 0.027 -0.351 0.016
LVEDWS -0.298 0.023
LVESWS -0.380 0.004
*Stepwise multiple regression analysis. A = late diastolic transmitral inflow, a’ = late diastolic mitral annular velocity, CMR = cardiac 
magnetic resonance imaging, E = early diastolic transmitral inflow, e’ = early diastolic mitral annular velocity, Ed = end-diastolic 
elastance, eGFR = estimated glomerular filtration rate, LGE = late gadolinium enhancement, LV = left ventricular, LVEDWS = left 
ventricular end-diastolic wall stress, LVESWS = left ventricular end-systolic wall stress, NT-proBNP = N-Terminal pro-B-type natriuretic 
peptide, s’ = systolic mitral annular velocity
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retrospectively, we only had LL sequence data. One study 
showed that LL-based T1 measurements agree well with T1 
using MOLLI (24) and it has been used in several studies 
(25). Therefore, use of LL-based T1 measurements is 
justified in this study. 
Myocardial Fibrosis and Diastolic Dysfunction in Patients 
with Non-Ischemic DCM
Diastolic function is a well-known important prognostic 
factor (4, 5, 26) and is correlated with myocardial fibrosis 
in patients with DCM (10). The presence of fibrosis reduces 
compliance of the ventricle and impairs diastolic function 
by increasing filling pressure (27). Our study confirmed 
that LV compliance decreased and diastolic wall stress 
increased in patients with LGE. In addition, post-T1, a 
surrogate marker of ECV, was independently related to the 
diastolic functional index, the LV remodeling index, and 
serum biomarkers of diastolic function, independent of 
LGE. Therefore, the combination of LGE and direct T1 value 
measurements in non-LGE myocardium can potentially 
provide better information about all myocardial tissue 
characteristics. One of the interesting findings of this 
study is that gadolinium distribution could be quantified 
using this LL T1 measurement technique, which added 
quantitative information to the LGE qualitative evaluation 
at the same time and location within the myocardium. 
The post-T1 measurement and its association with clinical 
outcomes need to be further investigated in longitudinal 
studies of patients with DCM.
Relationship between Extracellular Space Expansion, LV 
Remodeling, and Neurohormonal Activation
Late gadolinium enhancement is currently accepted 
as a non-invasive gold standard method for detecting 
replacement fibrosis. However, diffuse interstitial fibrosis, 
which exists in all patients with DCM of varying degrees, 
cannot be quantified with this technique. Although the 
Table 5. Correlation with Post-Contrast T1 Values after LGE 
Adjustment
Standardized 
Coefficient
P
Adjustment by presence of LGE
LV mass/volume ratio 0.339 0.010
NT-proBNP -0.340 0.034
Adjustment by septal LGE
LV mass/volume ratio 0.360 0.006
NT-proBNP -0.419 0.008
Adjustment by mid-wall LGE
LV mass/volume ratio 0.387 0.003
NT-proBNP -0.473 0.002
LGE = late gadolinium enhancement, LV = left ventricular, NT-
proBNP = N-Terminal pro-B-type natriuretic peptide
Table 4. Univariate and Multivariable Analysis with NT-proBNP (n = 40) Showing Association with Post-Contrast T1 Values
Univariate Analysis Multivariate Analysis
r P β P
Age 0.037 0.820
eGFR 0.160 0.324
LVEDV 0.086 0.598
LVESV 0.054 0.741
Stroke volume 0.224 0.164
LV ejection fraction (CMR) 0.229 0.156
LV mass (CMR) 0.346 0.029 0.388 0.005
LV mass/volume ratio 0.304 0.057
E/e’ -0.296 0.064
s’ 0.466 0.003 0.447 0.002
e’ 0.345 0.029
a’ 0.500 0.008
E/e’/stroke volume (Ed) -0.360 0.023
LVEDWS -0.348 0.028
LVESWS -0.304 0.057
NT-proBNP -0.464 0.003 -0.339 0.017
a’ = late diastolic mitral annular velocity, CMR = cardiac magnetic resonance imaging, E = early diastolic transmitral inflow, e’ = early 
diastolic mitral annular velocity, Ed = end-diastolic elastance, eGFR = estimated glomerular filtration rate, LV = left ventricular, LVEDV = left 
ventricular end-diastolic volume, LVEDWS = left ventricular end-diastolic wall stress, LVESV = left ventricular end-systolic volume, LVESWS = 
left ventricular end-systolic wall stress, NT-proBNP = N-Terminal pro-B-type natriuretic peptide, s’ = systolic mitral annular velocity
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presence of LGE can be a marker of severe diffuse interstitial 
fibrosis in LGE-negative myocardium, as supported by our 
observations, it is not possible to quantify the degree of 
diffuse interstitial fibrosis or the degree of extracellular 
expansion. However, quantifying the degree of extracellular 
space expansion is very important because the non-LGE 
area represents 80–90% of the entire LV in a patient with 
DCM, suggesting that the non-LGE area could be a main 
determinant of LV structural remodeling and mechanical 
properties. The relationship between decreased post-T1, an 
index of increased ECV, and a decrease in the mass/volume 
ratio, an index of LV remodeling due to myocyte atrophy 
in patients with DCM, is consistent with a previous study 
(28). One of the interesting findings of this study is that 
the relationship between LVEDWS and NT-proBNP became 
significantly weaker after introducing LGE or post-contrast 
T1 values, whereas the post-contrast T1 values remained 
significant, suggesting that post-contrast T1 values or 
ECV could be an important determinant of the NT-proBNP 
level with a given LVEDWS. This finding also justifies the 
importance of tissue characterization of the non-LGE area 
using T1-measurements for further risk stratification or 
predicting the prognosis. 
N-Terminal pro-B-type natriuretic peptide is secreted 
from the ventricles in response to excess stretching of 
cardiomyocytes modulated by calcium ions (29, 30). 
However, an opposite hypothesis can also be applied, 
as previous studies have shown that the stretch-induced 
production of NT-proBNP from fibroblasts modulates 
extracellular protein turnover and extracellular space or 
fibrosis. Our results partially support the role of NT-proBNP 
in ECV expansion and LV remodeling. Excess collagen 
deposition may increase stiffness, whereas excess collagen 
degradation may contribute to ventricular dilatation 
(29, 30). The relationship between the post-contrast T1 
values and the LV mass/volume ratios became weaker after 
adjusting for NT-proBNP. In addition, the relationship 
between ECV and remodeling is partly mediated by 
neurohormonal activation and increased extracellular matrix 
turnover by NT-proBNP. Therefore, expansion of the ECV 
due to increased wall stress can directly trigger the release 
of NT-proBNP from cardiomyocytes or fibroblasts in the 
extracellular space. In this study, the correlation between 
post-contrast T1 values, ECV markers, LVEDWS, and post-
contrast T1 values was weaker than that to the LV mass/
volume ratio and NT-proBNP. ECV cannot be easily predicted 
using hemodynamic indices, and NT-proBNP level changed 
due to volume status. Therefore, directly measuring ECV 
would provide the specific myocardial tissue characteristics 
without the effects of various hemodynamic factors. The 
clinical implications in terms of predicting the prognosis or 
further remodeling of higher ECV warrant further long-term 
follow-up studies.
Limitations
The major limitation of our study is the small sample size, 
cross-sectional design, and lack of follow-up data. The study 
lacked a control group, which is needed to demonstrate 
that our findings are unique to the DCM population. In 
addition, we were unable to measure pre-contrast (native) 
T1 values, and there were some time intervals between CMR, 
echocardiography, and NT-proBNP sampling. Particularly, 
NT-proBNP level and echo Doppler measures were dependent 
on the patient’s volume status. Finally, post-T1 values were 
affected by the contrast dose, scan timing, renal function, 
hematocrit, and heart rate. The T1 values measured in our 
study were lower than those of a previous study; probably 
because we used post-10 minutes images rather than post-
15 minutes images, which have been used in most other 
studies. However, the same MRI scanner with the same 
protocol was used when performing CMR to avoid further 
limitations. Prospective studies with a larger sample size 
are required.
Conclusions
The degree of extracellular space expansion as 
assessed by post-contrast T1 values was closely related 
to LV remodeling, diastolic function, and neurohormonal 
activation as determined by NT-proBNP level, independent 
of systolic function and LGE.
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